Dr. Brawer on the Results of the Prolaris Test for Patients Prostate Cancer
Michael Brawer, MD
Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the results of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.
It has been known for a long time that African-American men not only have more prostate cancer, but also have worse prostate cancer for reasons that are still unknown, states Brawer.
Ongoing studies are attempting to determine if there are biological differences that cause this increase in cancer, explains Brawer.